CHICAGO--(BUSINESS WIRE)--Toshiba America Medical Systems, Inc. is committed to new CT clinical applications that improve throughput and workflow, while further reducing contrast and radiation dose to patients. At this year’s American College of Cardiology annual meeting in Chicago, March 30 – April 1, 2008 (Booth # 8001), Toshiba will demonstrate new applications that embody this commitment – SURECardio™ Prospective and Variable Helical Pitch (vHP), which was recently cleared by the FDA.
